BIDMC investigator receives $50,000 CCF grant for research on pediatric cardiomyopathy

NewsGuard 100/100 Score

Maria Kontaridis, PhD, an investigator in the Division of Cardiology at Beth Israel Deaconess Medical Center (BIDMC), has received a $50,000 grant from the Children's Cardiomyopathy Foundation (CCF) for her research on pediatric cardiomyopathy.

A chronic and potentially life-threatening inherited heart disease, hypertrophic cardiomyopathy (HCM) is the leading cause of sudden death in young people.

Kontaridis's research focuses on genetic mutations related to HCM, specifically genetic mutations in the PTPN11 gene, which has been linked to nearly all cases of a rare disease known as LEOPARD Syndrome.

"More than 90 percent of LEOPARD syndrome cases exhibit hypertrophic cardiomyopathy," explains Kontaridis. "This grant will enable my laboratory to study how the mutations that cause LEOPARD syndrome affect the heart during development, and how these mutations may lead to the development of pediatric cardiomyopathy in children. Ultimately, we hope that the results of our research will serve as a stepping stone in identifying potential therapies for HCM, and we are very grateful for the CCF's support of our work."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Unraveling the complexities of muscle repair in diabetes: A call for targeted research and therapies